# A Double-blind, Randomized, Parallel Group, Fase III Comparative Study With Rose Hip Powder Powder and Placebo Given to Patients With Mild to Moderate Osteoarthritis in the Knee or/and Hip

> **NCT01459939** · PHASE3 · COMPLETED · sponsor: **Hyben Vital ApS** · enrollment: 120 (actual)

## Conditions studied

- Pain
- Activities of Daily Living
- Quality of Life

## Interventions

- **DIETARY_SUPPLEMENT:** Rose-hip powder capsules
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01459939
- **Lead sponsor:** Hyben Vital ApS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-02
- **Final completion:** 2012-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2012-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01459939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01459939, "A Double-blind, Randomized, Parallel Group, Fase III Comparative Study With Rose Hip Powder Powder and Placebo Given to Patients With Mild to Moderate Osteoarthritis in the Knee or/and Hip". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01459939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*